Entourage Health Corp.
ETRGF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -0.4% | -3.3% | 43.6% | – |
| Gross Profit | $0 | -$0 | -$0 | -$0 |
| % Margin | 9.1% | -48.6% | -27.7% | -82.2% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -52.6% | -113.4% | -68.9% | -153.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -113.4% | -432.5% | -226.3% | -338% |
| EPS Diluted | -0.15 | -0.58 | -0.38 | -0.48 |
| % Growth | 74.1% | -52.6% | 20.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |